|
1
|
Longacre L Schwartz, Kloner RA, Arai AE,
Baines CP, Bolli R, Braunwald E, Downey J, Gibbons RJ, Gottlieb RA,
Heusch G, et al: New horizons in cardioprotection: Recommendations
from the 2010 National Heart, Lung and Blood Institute Workshop.
Circulation. 124:1172–1179. 2011. View Article : Google Scholar :
|
|
2
|
Forouzanfar MH, Moran AE, Flaxman AD, Roth
G, Mensah GA, Ezzati M, Naghavi M and Murray CJ: Assessing the
global burden of ischemic heart disease, part 2: Analytic methods
and estimates of the global epidemiology of ischemic heart disease
in 2010. Glob Heart. 7:331–342. 2012. View Article : Google Scholar :
|
|
3
|
Zamilpa R and Lindsey ML: Extracellular
matrix turnover and signaling during cardiac remodeling following
MI: Causes and consequences. J Mol Cell Cardiol. 48:558–563. 2010.
View Article : Google Scholar
|
|
4
|
Ishitani T, Hirao T, Suzuki M, Isoda M,
Ishitani S, Harigaya K, Kitagawa M, Matsumoto K and Itoh M:
Nemo-like kinase suppresses Notch signalling by interfering with
formation of the Notch active transcriptional complex. Nat Cell
Biol. 12:278–285. 2010.
|
|
5
|
Gude N and Sussman M: Notch signaling and
cardiac repair. J Mol Cell Cardiol. 52:1226–1232. 2012. View Article : Google Scholar :
|
|
6
|
Li Y, Hiroi Y and Liao JK: Notch signaling
as an important mediator of cardiac repair and regeneration after
myocardial infarction. Trends Cardiovasc Med. 20:228–231. 2010.
View Article : Google Scholar :
|
|
7
|
Gude NA, Emmanuel G, Wu W, Cottage CT,
Fischer K, Quijada P, Muraski JA, Alvarez R, Rubio M, Schaefer E
and Sussman MA: Activation of Notch-mediated protective signaling
in the myocardium. Circ Res. 102:1025–1035. 2008. View Article : Google Scholar :
|
|
8
|
Kratsios P, Catela C, Salimova E, Huth M,
Berno V, Rosenthal N and Mourkioti F: Distinct roles for
cell-autonomous Notch signaling in cardiomyocytes of the embryonic
and adult heart. Circ Res. 106:559–572. 2010. View Article : Google Scholar
|
|
9
|
Li Y, Hiroi Y, Ngoy S, Okamoto R, Noma K,
Wang CY, Wang HW, Zhou Q, Radtke F, Liao R and Liao JK: Notch1 in
bone marrow-derived cells mediates cardiac repair after myocardial
infarction. Circulation. 123:866–876. 2011. View Article : Google Scholar :
|
|
10
|
Lee JH, Suk J, Park J, Kim SB, Kwak SS,
Kim JW, Lee CH, Byun B, Ahn JK and Joe CO: Notch signal activates
hypoxia pathway through HES1-dependent SRC/signal transducers and
activators of transcription 3 pathway. Mol Cancer Res. 7:1663–1671.
2009. View Article : Google Scholar
|
|
11
|
Lee SH, Wolf PL, Escudero R, Deutsch R,
Jamieson SW and Thistlethwaite PA: Early expression of angiogenesis
factors in acute myocardial ischemia and infarction. N Engl J Med.
342:626–633. 2000. View Article : Google Scholar
|
|
12
|
Li X, Zhao H, Wu Y, Zhang S, Zhao X, Zhang
Y, Wang J, Wang J and Liu H: Up-regulation of hypoxia-inducible
factor-1α enhanced the cardioprotective effects of ischemic
postconditioning in hyperlipidemic rats. Acta Biochim Biophys Sin
(Shanghai). 46:112–118. 2014. View Article : Google Scholar
|
|
13
|
Chunli L, Yu C, Wenwei L, Haitao Y, Biao S
and Shijie Y: Effects of Astragalus saponins on ischemic scope,
epicardial ECG, myocardial enzymes in acute myocardial infarcted
dog heart. Baiqiuen Yike Daxue Xuebao. 21:111–113. 1995.(In
Chinese).
|
|
14
|
Zhang Z, Chen LX, Qin LM and B J: Effect
of Astragalus on hemodynamics and oxygen free radical in myocardial
ischemia reperfusion injury in rats. Chin J Info Trad Chin Med.
7:7–8. 2000.(In Chinese).
|
|
15
|
Feng L, Meng D, Chen XJ, Yang D and Zhang
JN: Protective action of Astragalosides on myocardial injury
induced by isoproterenol in rats. Chin Pharm J. 1313–1316. 2006.(In
Chinese).
|
|
16
|
Wang N, Zhu K, Yue H, et al: Protective
effects of Astragalus saponins on cardiomyocytes injury induced by
oxidative stress. J Hebei Trad Chin Med Pharmacol. 22:8–9. 2007.(In
Chinese).
|
|
17
|
Jia H, Wweiping J, Jiajie L and Li WZ:
Protective effect of astragalosides on myocardial damage in
diabetic mice. Acta Universitatis Medicinalis Anhui. 290–294.
2012.
|
|
18
|
Han D, Zhang YW, Liu M, et al: The
hemodynamic and antioxidant effects of Astragaloside on ventricular
remodeling rats. Chin J Lab Diag. 17:1956–1959. 2013.(In
Chinese).
|
|
19
|
Cao BD, Jiang W, Wang HD, Wang LY, Yu JM
and Zhang XB: The effect of Astragalus on VEGF in ischemic
myocardium of rats. Chin J Crit Care Med. 1033–1035. 2014.
|
|
20
|
Blanco P, ampín J, García Rivero SA,
Cepeda XL Otero, Vázquez Boquete A, Vila J Forteza and Fonseca R
Hinojal: Immunohistochemical expression of HIF-1alpha in response
to early myocardial ischemia. J Forensic Sci. 51:120–124. 2006.
View Article : Google Scholar
|
|
21
|
Parisi Q, Biondi-Zoccai GG, Abbate A,
Santini D, Vasaturo F, Scarpa S, Bussani R, Leone AM, Petrolini A,
Silvestri F, et al: Hypoxia inducible factor-1 expression mediates
myocardial response to ischemia late after acute myocardial
infarction. Int J Cardiol. 99:337–339. 2005. View Article : Google Scholar
|
|
22
|
Adluri RS, Thirunavukkarasu M, Dunna NR,
Zhan L, Oriowo B, Takeda K, Sanchez JA, Otani H, Maulik G, Fong GH
and Maulik N: Disruption of hypoxia-inducible transcription
factor-prolyl hydroxylase domain-1 (PHD-1-/-) attenuates ex vivo
myocardial ischemia/reperfusion injury through hypoxia-inducible
factor-1α transcription factor and its target genes in mice.
Antioxid Redox Signal. 15:1789–1797. 2011. View Article : Google Scholar :
|
|
23
|
Poynter JA, Manukyan MC, Wang Y, Brewster
BD, Herrmann JL, Weil BR, Abarbanell AM and Meldrum DR: Systemic
pretreatment with dimethyloxalylglycine increases myocardial
HIF-1alpha and VEGF production and improves functional recovery
after acute ischemia/reperfusion. Surgery. 150:278–283. 2011.
View Article : Google Scholar
|
|
24
|
Kido M, Du L, Sullivan CC, Li X, Deutsch
R, Jamieson SW and Thistlethwaite PA: Hypoxia-inducible factor
1-alpha reduces infarction and attenuates progression of cardiac
dysfunction after myocardial infarction in the mouse. J Am Coll
Cardiol. 46:2116–2124. 2005. View Article : Google Scholar
|
|
25
|
Ong SG and Hausenloy DJ: Hypoxia-inducible
factor as a therapeutic target for cardioprotection. Pharmacol
Ther. 136:69–81. 2012. View Article : Google Scholar
|
|
26
|
Zhou XL and Liu JC: Role of Notch
signaling in the mammalian heart. Braz J Med Biol Res. 47:1–10.
2014. View Article : Google Scholar
|
|
27
|
Croquelois A, Domenighetti AA, Nemir M,
Lepore M, Rosenblatt-Velin N, Radtke F and Pedrazzini T: Control of
the adaptive response of the heart to stress via the Notch1
receptor pathway. J Exp Med. 205:3173–3185. 2008. View Article : Google Scholar :
|
|
28
|
Yu B and Song B: Notch 1 signalling
inhibits cardiomyocyte apoptosis in ischaemic postconditioning.
Heart Lung Circ. 23:152–158. 2014. View Article : Google Scholar
|
|
29
|
Pei H, Yu Q, Xue Q, Guo Y, Sun L, Hong Z,
Han H, Gao E, Qu Y and Tao L: Notch1 cardioprotection in myocardial
ischemia/reperfusion involves reduction of oxidative/nitrative
stress. Basic Res Cardiol. 108:3732013. View Article : Google Scholar
|
|
30
|
Meng D, Chen XJ, Yang D, Bian YY, Li P and
Zhang JN: Effects of Astragaloside on the cultivation of calcium
overload in rat cardiac myocytes. Chin J Clin Rehab. 8:462–463.
2004.
|
